Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials-data from the prospective German Tumour Registry Lymphatic Neoplasms

about

Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials-data from the prospective German Tumour Registry Lymphatic Neoplasms

Item

http://www.wikidata.org/entity/Q58803972

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2018

@uk

name

Survival of non-transplant pat ...... r Registry Lymphatic Neoplasms

@en

Survival of non-transplant pat ...... r Registry Lymphatic Neoplasms

@nl

type

Item

label

Survival of non-transplant pat ...... r Registry Lymphatic Neoplasms

@en

Survival of non-transplant pat ...... r Registry Lymphatic Neoplasms

@nl

prefLabel

Survival of non-transplant pat ...... r Registry Lymphatic Neoplasms

@en

Survival of non-transplant pat ...... r Registry Lymphatic Neoplasms

@nl

P1476

Survival of non-transplant pat ...... r Registry Lymphatic Neoplasms

@en

P2093

Ali Aldaoud

http://www.w3.org/2001/XMLSchema#string

Martina Jänicke

http://www.w3.org/2001/XMLSchema#string

Martine Klausmann

http://www.w3.org/2001/XMLSchema#string

Natalie Wetzel

http://www.w3.org/2001/XMLSchema#string

Ulrich Hutzschenreuter

http://www.w3.org/2001/XMLSchema#string

Wolfgang Knauf

http://www.w3.org/2001/XMLSchema#string

and the TLN-Group (Tumour Registry Lymphatic Neoplasms)

http://www.w3.org/2001/XMLSchema#string

P2860

Innovative agents in multiple myeloma

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Myeloma in the Real World: What Is Really Happening?

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.

Treatment of Non-transplant patients with multiple myeloma: routine treatment by office-based haematologists in Germany--data from the prospective Tumour Registry Lymphatic Neoplasms (TLN).

PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma.

Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.

Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials.

Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials.

P304

2437-2445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-018-3449-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stephanie Dille

Norbert Marschner

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30069704

http://www.w3.org/2001/XMLSchema#string

P921

hematology

P932

6208687

http://www.w3.org/2001/XMLSchema#string